Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | +8.54% |
|
+11.25% | -87.72% |
01/07 | Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from Russell 3000E Growth Index | CI |
01/07 | Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from Russell 2000 Growth Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.72% | 6.76Cr | |
+59.01% | 85TCr | |
+38.56% | 63TCr | |
-4.31% | 36TCr | |
+17.13% | 32TCr | |
+9.32% | 30TCr | |
+14.15% | 24TCr | |
+3.11% | 22TCr | |
+16.98% | 22TCr | |
+12.71% | 17TCr |
- Stock Market
- Equities
- MRNS Stock
- News Marinus Pharmaceuticals, Inc.
- Transcript : Marinus Pharmaceuticals, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-16-2020 11